Current Enzyme Inhibition
Volume 17, 3 Issues, 2021
ISSN: 1875-6662 (Online)
ISSN: 1573-4080 (Print)
This journal supports open access
ISSN: 1875-6662 (Online)
ISSN: 1573-4080 (Print)
This journal supports open access
Open Access Articles
Inhibition by Substrates of a Coniferyl Alcohol Dehydrogenase Purified from Sugarcane Stalks
, 2019; 15(3): 206 - 214Borja Alarcón, Roberto de Armas, Carlos Vicente and María E. Legaz*
Exploring Molecular Docking Studies of Alanine Racemase Inhibitors from Elettaria cardamomum
, 2019; 15(2): 91 - 102Rosy Kumari, Ratish Chandra Mishra, Shivani Yadav and Jaya Parkash Yadav*
Should Olanzapine be Advocated Over Conventional Anti-Emetics for the Prevention of Chemotherapy-Induced Nausea and Vomiting? An Updated Meta-Analysis of Randomized Control Trials
, 2019; 15(2): 80 - 90Eshak Ibrahim Bahbah*, Ahmed Ramadan Abdalla, Khalid Abdelshafy, Ahmed Diaa Almohandes , Amr Menshawy, Mohamed Abd Elalem Aziz, Mahmoud Ahmed Ebada, Awad Hegab and Ahmed Negida*
Kinetic Models to Produce an Antioxidant by Enzymatic Hydrolysis of Bovine Plasma Protein Using a High Substrate Concentration
, 2019; 15(2): 144 - 153Nathalia A. Gómez*, Leidy J. Gómez and José E. Zapata
Synthesis and Pancreatic Lipase Inhibitory Activity of Phenacyl Esters of N-Aroyl Amino Acids
, 2019; 15(2): 133 - 143Maida Engels Selvaraj Emimmal and Veintramuthu Sankar*
Identification of New Enterococcus faecalis Peptide Deformylase Inhibitors
, 2019; 15(2): 120 - 132Amina Merzoug*, Abdelouahab Chikhi, Abderrahmane Bensegueni, Hanane Boucherit and Sawsen Hadef
Application of Remote Ischemic Preconditioning in Patients Undergoing Chemotherapy with Anthracyclines
, 2019; 15(2): 114 - 119Simone Meneghetti Zatta, Neif Murad, Beatriz da Costa Aguiar Alves, Ligia Ajaime Azzalis, Virginia Berlanga Campos Junqueira, Roberto Odebrecht Rocha, Marcelo Rodrigues Bacci, David Feder, Antonio Carlos Palandri Chagas, Fernando Adami and Fernando Luiz Affonso Fonseca*
Anticholinesterase and Antioxidant Activities of Spilanthes filicaulis Whole Plant Extracts for the Management of Alzheimer’s Disease
, 2019; 15(2): 103 - 113Taiwo O. Elufioye *, Cynthia C. Unachukwu and Adebola O. Oyedeji
High Antioxidant Capacities and Anti-inflammatory Effects of Hammada elegans Botsch. Extracts: An in vitro Assessment
, 2019; 15(1): 55 - 68Bensafiddine Feriha, Asseli Brahim, Mahfoudi Reguia, Djeridane Amar* and Yousfi Mohamed
Effect of Substitution Pro32Thr on the Interaction between Dimer Subunits of Human Phosphatase ITPA
, 2019; 15(1): 46 - 54Ermuhammad B. Dushanov* and Natalia A. Koltovaya
Characterization of a New Allelic Variant of Triosephosphate Isomerase from the LNCaP Human Prostate Cancer Cell Line: Enzyme Inhibition and Spectroscopic Studies
, 2017; 13(3): 184 - 190Valeria Guzmán-Luna, Leticia Olvera-Rodríguez, Peniel Bustamante-Villalobos and Gloria Saab-Rincón*
Molecular Docking Study of a Series of Substituted Xanthone Derivatives as Novel COX-2 Inhibitors Targeting Prostaglandin Endoperoxide Synthase -2
, 2016; 12(2): 195 - 204Aparoop Das, Urvashee Gogoi, Junmoni Kalita and Satyasish Sandilya
An Additional Method for Analyzing the Reversible Inhibition of an Enzyme Using Acid Phosphatase as a Model
, 2015; 11(2): 140 - 146Jordan M. Baumhardt, Benjamin M. Dorsey, Craig C. McLauchlan and Marjorie A. Jones
Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense
, 2011; 7(2): 71 - 78Martin Joyce-Brady and Jun Hiratake
Editor-in-Chief
Claudiu T. Supuran
(83932 citations)
University of Florence
Florence
(Italy)
Biography
(83932 citations)
University of Florence
Florence
Biography
Biography of Claudiu T. Supuran
CLAUDIU T. SUPURAN is professor of medicinal chemistry at the Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, University of Florence, Italy. He has published more than 1250 papers, his Hirsch factor is h = 110; the number of citations since 1995 > 49800. His main research interest is on enzyme inhibitors, and especially carbonic anhydrase inhibitors, of which he discovered several new classes in the last years. One of the sulfonamides discovered in his group entered Phase I clinical trials in 2014 for the treatment of advanced, metastatic solid tumors. He is Editor-in-Chief of Expert Opinion on Therapeutic Patents, Journal of Enzyme Inhibition and Medicinal Chemistry, Current Enzyme Inhibition, etc. For the last 25 years the main interest of his research was focused on metallo-enzymes and their modulators of activity. In 2013 he was rated as the most cited scientists in Pharmacology & Toxicology by LabTimes (LabTimes 2013, 5, 38).
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Enzyme Inhibition Journal was launched in 2005. Dr. Claudiu T. Supuran serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net